HomeQuestion

Do you use biologic DMARDs for active axial spondyloarthritis in transplant patients on long-term anti-rejection therapy?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How would you approach management of a patient with ankylosing spondylitis who was doing well on tofacitinib, but experienced a STEMI while on therapy?

How would you approach treatment of active axial spondyloarthritis refractory to NSAID in a patient with concurrent autoinflammatory disease on long-term anti-IL-1 therapy?

How do you assess the potential role of obesity in driving inflammatory joint symptoms?

What would be your treatment approach for a patient with concomitant diagnoses of multiple myeloma and axial spondyloarthritis?

Does SI joint erosion on MRI pelvis push you to use TNF inhibitors over NSAIDs as first line for axial spondyloarthritis?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.